organizationBehavioral Health / Mental Health ServicesUnited States

Sheppard Pratt

The largest private, nonprofit mental health and behavioral health system in the United States.

Sheppard Pratt is a private, nonprofit behavioral health system headquartered in Towson, Maryland, founded in 1853. It is recognized as the largest private, nonprofit provider of mental health, special education, substance use, developmental disability, and social services in the United States. Rooted in its Quaker heritage, the organization's values are guided by the testimonies of simplicity, peace, integrity, community, and equality.

The organization offers over 160 programs across 16 Maryland counties, operating from 58 locations, and serves more than 70,000 individuals annually. Services span a comprehensive continuum of care delivered in hospitals, schools, community mental health clinics, and patients' homes. Sheppard Pratt employs between 5,000 and 10,000 staff and is funded through patient services revenue, government and private foundation grants, philanthropic contributions, and an endowment.

Sheppard Pratt also maintains a strong educational mission, running psychiatry residency and fellowship programs considered among the most competitive in the nation, alongside training programs for nursing and occupational therapy students. As a leading behavioral health system, Sheppard Pratt is highly relevant to innovations in mental health care delivery, workforce training, and community-based treatment models.

Ideas that could help Sheppard Pratt

Psilocybin Depression Remission Clinic
A specialty outpatient clinic offering protocol-driven psilocybin-assisted therapy (25 mg sessions with structured psychological support) for patients with moderate-to-severe MDD or treatment-resistant depression who have not responded to SSRIs, backed by evidence of durable 12-month remission.
Why it helps: One of the largest US psychiatric hospitals, it participated in academic psilocybin research and has the clinical staff, compliance infrastructure, and TRD patient population to run a licensed psilocybin program.